Fonar CEO disputes MRI Nobel
This article was originally published in The Gray Sheet
Executive Summary
2003 Nobel Prize in physiology or medicine awarded to Paul Lauterbur, MD, University of Illinois, for discovering "the possibility to create a two-dimensional picture by introducing gradients in the magnetic field," and Peter Mansfield, MD, University of Nottingham in Britain, for demonstrating "how the [gradients] could be mathematically analyzed, which made it possible to develop a useful imaging technique." The prize is strongly contested by Fonar founder and CEO Raymond Damadian, MD, who has taken out full-page ads in newspapers such as the Washington Post, insisting he deserves a third of the $1.3 mil. award for making initial discoveries enabling MRI technology. The Post ad, which cost approximately $84,000, accuses the Nobel Committee of "attempting to rewrite history." Fonar manufactures the Stand-Up MRI, distributed by GE Medical Systems. Roughly 57 systems have been sold to date...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.